Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC

Abstract

The generation of strong serological responses to protein antigens in experimental animals usually requires the use of potent adjuvants, most of which cannot be used in human or veterinary vaccines because of deleterious side effects1,2. Attempting to circumvent this problem, we have assessed an adjuvant-free antigen-delivery system based on the hypothesis that antigen coupled to monoclonal antibodies (mAbs) specific for class II major histocompatibility complex (MHC) determinants should be 'targeted' onto antigen-presenting cells, thus facilitating recognition by helper T cells3. We found that the biotin-binding protein avidin4 could generate a serological response in mice, without adjuvant, when injected coupled to a biotinylated anti-class II MHC mAb. Equivalent amounts of avidin mixed with the non-biotinylated form of the same mAb failed to elicit a response. A targeting effect was demonstrated at low levels of injected conjugate because only mice bearing the appropriate class II antigens responded. Responses were also seen with a protein antigen other than avidin, offering a new, adjuvant-free approach to subunit vaccine construction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. 1. Warren, H. S., Vogel, F. R. & Chedid, L. A. A. Rev. Immun. 4, 369–388 (1986). 2. Chapel, H. M. & August, P. J. Clin. exp. Immun. 24, 538–541 (1976). 3. Schwartz, R. H. A. Rev. Immun. 3, 237–261 (1985). 4. Green, N. M., Adv. Protein Chem. 29, 85–133 (1975). 5. Friedman, A. & Cohen, I. R. Immunogenetics 18, 267–275 (1983). 6. Borel, Y. Immun. Rev. 50, 71–104 (1980). 7. Matis, L. A., Glimcher, L. H., Paul, W. E. & Schwartz, R. H. Proc. natn. Acad. Sci. U.S.A. 80, 6019–6023 (1983). 8. Palacios, R. Proc. natn. Acad. Sci. U.S.A. 82, 6652–6656 (1985). 9. Janeway, C. A. Jr in Strategies of Immune Regulation (eds Sercarz, E. & Cunningham, A. 179–198 (Academic, London, 1983). 10. Leserman, L. Immun. Today 6, 352–355 (1985). 11. Kawamura, H. & Berzofsky, J. A. /. Immun. 136, 58–65 (1986). 12. Liew, F. Y. Clin. exp. Immun. 62, 225–241 (1985). 13. Oi, V. T., Jones, P. P., Coding, J. W., Herzenberg, L. A. & Herzenberg, L. A. Curr. Topics Microbiol. Immun. 81, 115–129 (1978). 14. Yewdell, J. W., Frank, E. & Gerhard, W. J. Immun. 126, 1814–1819 (1981). 15. Ey, P. L., Prowse, S. J. & Jenkin, C. R. Immunochemistry 15, 429–436 (1978). 16. Goding, J. W. Monoclonal Antibodies: Principles and Practice, 230–233 (Academic, London, 1983). 17. Ozato, K., Mayer, N. & Sachs, D. /. Immun. 124, 533–540 (1980). 18. Lamoyi, E. & Nisonoff, A. J. Immun. Meth. 56, 235–243 (1983).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carayanniotis, G., Barber, B. Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC. Nature 327, 59–61 (1987). https://doi.org/10.1038/327059a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/327059a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing